|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 655291-655315 of 2310128 (92406 Page(s) Totally)
<< < 26207 26208 26209 26210 26211 26212 26213 26214 26215 26216 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2007 |
Phase Ii Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
林家齊; 徐志宏; 黃昭源; 鄭安理; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; HUANG, CHAO-YUAN; CHENG, ANN-LII; PU, YEONG-SHIAU |
| 臺大學術典藏 |
2020-05-25T07:35:33Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Vogelzang N.J; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:17Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:46:59Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Cheng A.-L.;Vogelzang N.J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-09-01T02:02:09Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:56Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S. |
| 國立臺灣大學 |
2007-01 |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (TP-HDFL) for Metastatic Urothelial Carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Pu, Nicholas J. Vogelzang Yeong-Shiau |
| 臺大學術典藏 |
2021-12-14T23:12:13Z |
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
|
Even, Caroline; Wang, Hung Ming; Li, Shau Hsuan; Ngan, Roger K.C.; Dechaphunkul, Arunee; Zhang, Li; Yen, Chia Jui; Chan, Po Chung; Chakrabandhu, Somvilai; Ma, Brigette B.Y.; Tanasanvimon, Suebpong; Lee, Victor H.F.; PEI-JEN LOU; Li, Zujun; Spira, Alexander I.; Sukari, Ammar; Guigay, Jo€el; McCune, Steven; Gonzalez-Maffe, Juan; Szpakowski, Sebastian; Yao, Yao; Liang, Hongzi; Mataraza, Jennifer; Sechaud, Romain; Manenti, Luigi; Lim, Darren W.T. |
| 國立成功大學 |
2021 |
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
|
Even, C.;Wang, H.-M.;Li, S.-H.;Ngan, R.K.-C.;Dechaphunkul, A.;Zhang, L.;Yen, C.-J.;Chan, P.C.;Chakrabandhu, S.;Ma, B.B.Y.;Tanasanvimon, S.;Lee, V.H.F.;Lou, P.-J.;Li, Z.;Spira, A.I.;Sukari, A.;Guigay, J.;McCune, S.;Gonzalez-Maffe, J.;Szpakowski, Szpakowski S.;Yao, Yao Y.;Liang, H.;Mataraza, J.;Sechaud, R.;Manenti, L.;Lim, D.W.-T. |
| 國立臺灣大學 |
2009 |
Phase Iib/Iii Double-Blind Randomized Trial of Bibw 2992, an Irreversible, Dual Inhibitor of Egfr and Her2 Plus Best Supportive Care (Bsc) Versus Placebo Plus Bsc in Patients with Nsclc Failing 1-2 Lines of Chemotherapy (Ct) and Erlotinib or Gefitinib (Lu
|
楊志新; YANG, CHIH-HSIN |
| 國家衛生研究院 |
2016-05 |
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, GK;Qin, SK;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, GM;Harris, WP;Chen, ZD;Hubner, R;Meyer, T;Bomalaski, JS;Lin, CC;Chao, Y;Chen, LT |
| 國立成功大學 |
2018 |
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G.K.;Qin, S.;Ryoo, B.-Y.;Lu, S.-N.;Yen, C.-J.;Feng, Y.-H.;Lim, H.Y.;Izzo, F.;Colombo, M.;Sarker, D.;Bolondi, L.;Vaccaro, G.;Harris, W.P.;Chen, Z.;Hubner, R.A.;Meyer, T.;Sun, W.;Harding, J.J.;Hollywood, E.M.;Ma, J.;Wan, P.J.;Ly, M.;Bomalaski, J.;Johnston, A.;Lin, C.-C.;Chao, Y.;Chen, L.-T. |
| 中國醫藥大學 |
2014-01 |
Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis.
|
(K. Kubota);(Y. Ichinose);(G. Scagliotti);(D. Spigel);(J. H. Kim);(T. Shinkai);(K. Takeda);(S.-W. Kim);夏德椿(Te-Chun Hsia);(R. K. Li);(B. J. Tiangco);(S. Yau);(W.-T. Lim);(B. Yao);(Y.-J. Hei);(K. Park)* |
| 國立成功大學 |
2013-09-20 |
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
|
Sequist, Lecia V.; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin |
| 國立臺灣大學 |
2013 |
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
|
Sequist, Lecia V.; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin; 楊志新 |
| 臺大學術典藏 |
2020-05-26T09:27:01Z |
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations
|
Sequist L.V;Chih-Hsin Yang;Yamamoto N;O'Byrne K;Hirsh V;Mok T;Geater S.L;Orlov S;Tsai C.-M;Boyer M;Su W.-C;Bennouna J;Kato T;Gorbunova V;Lee K.H;Shah R;Massey D;Zazulina V;Shahidi M;Schuler M.; Sequist L.V; CHIH-HSIN YANG; Yamamoto N; O'Byrne K; Hirsh V; Mok T; Geater S.L; Orlov S; Tsai C.-M; Boyer M; Su W.-C; Bennouna J; Kato T; Gorbunova V; Lee K.H; Shah R; Massey D; Zazulina V; Shahidi M; Schuler M. |
| 國立成功大學 |
2023 |
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
|
Sequist, L.V.;Yang, J.C.-H.;Yamamoto, N.;O'Byrne, K.;Hirsh, V.;Mok, T.;Geater, S.L.;Orlov, S.;Tsai, C.-M.;Boyer, M.;Su, W.-C.;Bennouna, J.;Kato, T.;Gorbunova, V.;Lee, K.H.;Shah, R.;Massey, D.;Zazulina, V.;Shahidi, M.;Schuler, M. |
| 中國醫藥大學 |
2003 |
Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-free Survival
|
林進清(Lin JC); 詹建勝(Jan JS); Hsu CY(Hsu CY); 梁文敏(Liang,Wen-Miin); 江榮山(Jiang RS); 王文綺(Wang WY) |
| 中國醫藥大學 |
2003 |
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival
|
Lin, JC; Jan, JS; Hsu, CY; Liang, WM; Jiang, RS; Wang, WY |
| 國家衛生研究院 |
2016-02 |
Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Wang-Gillam, A;Li, CP;Bodoky, G;Dean, A;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Hubner, R;Chiu, CF;Schwartsmann, G;Siveke, JT;Braiteh, FS;Moyo, VM;Belanger, B;Bayever, E;Von Hoff, DD;Chen, LT |
| 臺大學術典藏 |
2017 |
Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7)
|
WEI-CHU CHIE; Bre'Dart, A. ; Anota, A. ; Young, T. ; Tomaszewski, K.A. ; Arraras, J.I. ; Moura De Albuquerque Melo, H. ; Schmidt, H. ; Friend, E. ; Bergenmar, M. ; Costantini, A. ; Vassiliou, V. ; Hureaux, J. ; Marchal, F. ; Tomaszewska, I.M. ; Chie, W.-C. ; Ramage, J. ; Beaudeau, A. ; Conroy, T. ; Bleiker, E. ; Kulis, D. ; Bonnetain, F. ; Aaronson, N.K. |
| 臺大學術典藏 |
2022-05-05T09:10:03Z |
Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7)
|
Br?dart A.; Anota A.; Young T.; Tomaszewski K.A.; Arraras J.I.; Moura De Albuquerque Melo H.; Schmidt H.; Friend E.; Bergenmar M.; Costantini A.; Vassiliou V.; Hureaux J.; Marchal F.; Tomaszewska I.M.; WEI-CHU CHIE; Ramage J.; Beaudeau A.; Conroy T.; Bleiker E.; Kulis D.; Bonnetain F.; Aaronson N.K.; the EORTC Quality of Life Group |
| 國立成功大學 |
2020 |
Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
|
Xiao, Y.;Zhang, S.;Dai, N.;Fei, G.;Goh, K.-L.;Chun, H.J.;Sheu, B.-S.;Chong, Chong C.F.;Funao, N.;Zhou, W.;Chen, M. |
| 臺大學術典藏 |
2020-05-26T09:26:35Z |
Phase III, randomized, placebo-controlled, double-blind trial of motesanib (AMG-706) in combination with paclitaxel and carboplatin in east asian patients with advanced nonsquamous non-small-cell lung cancer
|
Chih-Hsin Yang;Lin C.-B;Lee K.-H;Cho E.K;Park K;Tanaka H;Ichinose Y;Yamada K;Kato T;Kaneda H;Hayashi H;Nakagawa K;Yoh K;Hida T;Oshita F;Yoshioka H;Hara K;Asato T;Kubota K; Kubota K; Asato T; Hara K; Yoshioka H; Oshita F; Hida T; Yoh K; Nakagawa K; Hayashi H; Kaneda H; Kato T; Yamada K; Ichinose Y; Tanaka H; Park K; Cho E.K; Lee K.-H; Lin C.-B; CHIH-HSIN YANG |
| 淡江大學 |
2019-07 |
Phase inversion in reusable baths (PIRB): a new polymer membrane fabrication method as applied to EVOH
|
Yan-Lin Su; Konstantinos G. Beltsios; Liao-Ping Cheng |
Showing items 655291-655315 of 2310128 (92406 Page(s) Totally)
<< < 26207 26208 26209 26210 26211 26212 26213 26214 26215 26216 > >>
View [10|25|50] records per page
|
